Success Metrics

Clinical Success Rate
93.8%

Based on 45 completed trials

Completion Rate
94%(45/48)
Active Trials
3(5%)
Results Posted
24%(11 trials)
Terminated
3(5%)

Phase Distribution

Ph phase_3
5
8%
Ph early_phase_1
2
3%
Ph phase_1
2
3%
Ph phase_4
4
7%
Ph phase_2
13
22%
Ph not_applicable
32
54%

Phase Distribution

4

Early Stage

13

Mid Stage

9

Late Stage

Phase Distribution58 total trials
Early Phase 1First-in-human
2(3.4%)
Phase 1Safety & dosage
2(3.4%)
Phase 2Efficacy & side effects
13(22.4%)
Phase 3Large-scale testing
5(8.6%)
Phase 4Post-market surveillance
4(6.9%)
N/ANon-phased studies
32(55.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.0%

45 of 50 finished

Non-Completion Rate

10.0%

5 ended early

Currently Active

3

trials recruiting

Total Trials

59

all time

Status Distribution
Active(4)
Completed(45)
Terminated(5)
Other(5)

Detailed Status

Completed45
unknown5
Terminated3
Recruiting2
Withdrawn2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
59
Active
3
Success Rate
93.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (3.4%)
Phase 12 (3.4%)
Phase 213 (22.4%)
Phase 35 (8.6%)
Phase 44 (6.9%)
N/A32 (55.2%)

Trials by Status

completed4576%
active_not_recruiting12%
enrolling_by_invitation12%
recruiting23%
terminated35%
unknown58%
withdrawn23%

Recent Activity

Clinical Trials (59)

Showing 20 of 59 trialsScroll for more
NCT07523841Not Applicable

Non-surgical Periodontitis Treatment With Aspirin and Omega-3

Active Not Recruiting
NCT04485871Not Applicable

Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids

Recruiting
NCT07363551Not Applicable

Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression

Recruiting
NCT07352618Not Applicable

"Effect of Omega-3 Supplementation as Add on Therapy on Glycemic Control and Lipid Profile in Type2 Diabetes Mellitus."

Enrolling By Invitation
NCT01248728Phase 2

Omega-3 Fatty Acids For Treatment Of Young Children With Autism (OMG)

Completed
NCT03994055Not Applicable

Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer

Completed
NCT00004448Phase 2

Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy

Completed
NCT06154408Not Applicable

Evaluating the Impact of Omega-3 Fatty Acid Supplementation (Soloways™) on Lipid Profiles in Adults With PPARG Polymorphisms

Completed
NCT02757872Phase 3

Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives

Completed
NCT02966899Not Applicable

Reversal of Right Ventricular Steatosis in Pulmonary Hypertension

Withdrawn
NCT05972798Not Applicable

Exploration of the Potential Mechanisms of n-3 Fatty Acids Supplementation in Depression and Cognitive Function in Patients With Late-life Depression

Completed
NCT03510884Phase 3

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

Completed
NCT05825976Not Applicable

Omega-3 Fatty Acid Supplementation and Tear Film Quality in Celiac Patients

Unknown
NCT02597439Phase 4

Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in Europe

Completed
NCT04161989Not Applicable

Omega 3 Plus Vaginal Progesterone on Birth Weight of Constitutionally Small for Gestational Age Fetuses

Completed
NCT05520437Not Applicable

Effect of Omega-3 Fatty Acids on Kynurenine Metabolism and Mood

Unknown
NCT03204266Early Phase 1

Oral Supplementation to Enhance Recovery Pilot Study

Completed
NCT02278965Phase 1

Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer

Completed
NCT02921048

Effects of Omega-3 Fatty Acids in Ambient Air Pollution Exposure in Healthy Adults

Completed
NCT02101970Not Applicable

Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women

Completed

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
59